Australia: Omnibus claims and the doctrine of equivalents

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Australia: Omnibus claims and the doctrine of equivalents

For many years, Australia has allowed omnibus claims, which take the form of "an apparatus substantially as hereinbefore described…". They have been utilised as a last line of defence for patentees when suing defendants.

Unfortunately, Australia does not have a strong doctrine of equivalence, found for example, in US jurisprudence. Hence, we have tended towards a literal infringement of claims.

Any hope that the omnibus claim would assist in finding non-literal infringement of patent applications has recently been dashed by our Full Federal Court in GlaxoSmithKline Australia Pty Ltd v Reckitt Benckiser Healthcare (UK) Ltd [2016] FCAFC 90.

The subject matter of the case dealt with a spill-free syringe dispensing system, which dominated the consumer market. The defendants had invented around the main claim and had developed an alternate syringe that the trial judge found had "exactly the same function". Unfortunately, for the patentee, the defendant's modifications meant that there was no literal infringement of the main claims.

The trial judge held that the omnibus claim could be utilised in a doctrine of equivalence sense to cover the "substance" of the invention. The Full Court overruled the trial judge, and, as a result, severely curtailed the operation of omnibus claims. The Court noted the overriding requirement for the omnibus claim to not extend beyond what was covered by the claims.

As a consequence, omnibus claims (which have recently also been curtailed by our Patents Act), are significantly reduced in effectiveness. Also, our courts appear to be moving towards a literal infringement position of patent claims which will be of great concern to patentees.

treloar.jpg

Peter Treloar


Shelston IPLevel 21, 60 Margaret StreetSydney NSW 2000, AustraliaTel: +61 2 9777 1111Fax: +61 2 9241 4666email@shelstonip.comwww.shelstonip.com

more from across site and SHARED ros bottom lb

More from across our site

IP leaders at Brandsmiths and Bird & Bird, who were on opposing sides at the UK Supreme Court in Iconix v Dream Pairs, unpick the landmark case and its ramifications
Magdalena Bonde discusses Abion’s AI experiments and reveals why an entrepreneurial mindset and a willingness to learn about a business are essential skills
Partner Ginevra Righini explains how she secured victory for the Comité Champagne in its fight against an EUTM application for ‘Nero Champagne’
Volkan Hamamcıoğlu joins us for our ‘Five minutes with’ series to discuss meditation, tackling deadlines, and taking inspiration from Hamlet
A $110 million US verdict against Apple and an appellate order staying a $39 million trademark infringement finding against Amazon were also among the top talking points
Attorneys are watching how AI affects trademark registrations and whether a SCOTUS ruling from last year will have broader free speech implications
Patent lawyers explain why they will be keeping an eye on the implications of a pharma case and on changes at the USPTO in the second half of 2025
The insensitive reaction to a UK politician crying on TV proves we have a long way to go before we can say we are tackling workplace wellbeing
Adrian Percer says he was impressed by the firm’s work on billion-dollar cases as well as its culture
In our latest interview with women IP leaders, Catherine Bonner at Murgitroyd discusses technology, training, and teaching
Gift this article